1887

Abstract

Dendritic cells (DC) are central to the initiation of immune responses, and various approaches have been used to target vaccines to DC in order to improve immunogenicity. Cannulation of lymphatic vessels allows for the collection of DC that migrate from the skin. These migrating DC are involved in antigen uptake and presentation following vaccination. Human replication-deficient adenovirus (AdV) 5 is a promising vaccine vector for delivery of recombinant antigens. Although the mechanism of AdV attachment and penetration has been extensively studied in permissive cell lines, few studies have addressed the interaction of AdV with DC. In this study, we investigated the interaction of bovine skin-migrating DC and replication-deficient AdV-based vaccine vectors. We found that, despite lack of expression of Coxsackie B–Adenovirus Receptor and other known adenovirus receptors, AdV readily enters skin-draining DC via an actin-dependent endocytosis. Virus exit from endosomes was pH independent, and neutralizing antibodies did not prevent virus entry but did prevent virus translocation to the nucleus. We also show that combining adenovirus with adjuvant increases the absolute number of intracellular virus particles per DC but not the number of DC containing intracellular virus. This results in increased trans-gene expression and antigen presentation. We propose that, in the absence of Coxsackie B–Adenovirus Receptor and other known receptors, AdV5-based vectors enter skin-migrating DC using actin-dependent endocytosis which occurs in skin-migrating DC, and its relevance to vaccination strategies and vaccine vector targeting is discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000581
2016-10-13
2022-01-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/10/2703.html?itemId=/content/journal/jgv/10.1099/jgv.0.000581&mimeType=html&fmt=ahah

References

  1. Adams W. C., Bond E., Havenga M. J., Holterman L., Goudsmit J., Karlsson Hedestam G. B., Koup R. A., Loré K. 2009; Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN. J Gen Virol 90:1600–1610 [View Article][PubMed]
    [Google Scholar]
  2. Ahi Y. S., Bangari D. S., Mittal S. K. 2011; Adenoviral vector immunity: its implications and circumvention strategies. Curr Gene Ther 11:307–320 [View Article][PubMed]
    [Google Scholar]
  3. Alba R., Bradshaw A. C., Parker A. L., Bhella D., Waddington S. N., Nicklin S. A., van Rooijen N., Custers J., Goudsmit J. et al. 2009; Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114:965–971 [View Article][PubMed]
    [Google Scholar]
  4. Ashbourne Excoffon K. J., Moninger T., Zabner J. 2003; The coxsackie B virus and adenovirus receptor resides in a distinct membrane microdomain. J Virol 77:2559–2567 [View Article][PubMed]
    [Google Scholar]
  5. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W. 1997; Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323 [View Article][PubMed]
    [Google Scholar]
  6. Bremner K. H., Scherer J., Yi J., Vershinin M., Gross S. P., Vallee R. B. 2009; Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit. Cell Host Microbe 6:523–535 [View Article][PubMed]
    [Google Scholar]
  7. Brooke G. P., Parsons K. R., Howard C. J. 1998; Cloning of two members of the SIRP alpha family of protein tyrosine phosphatase binding proteins in cattle that are expressed on monocytes and a subpopulation of dendritic cells and which mediate binding to CD4 T cells. Eur J Immunol 28:1–11 [View Article][PubMed]
    [Google Scholar]
  8. Burckhardt C. J., Suomalainen M., Schoenenberger P., Boucke K., Hemmi S., Greber U. F. 2011; Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane lytic protein exposure. Cell Host Microbe 10:105–117 [View Article][PubMed]
    [Google Scholar]
  9. Cao W., Henry M. D., Borrow P., Yamada H., Elder J. H., Ravkov E. V., Nichol S. T., Compans R. W., Campbell K. P., Oldstone M. B. 1998; Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079–2081 [View Article][PubMed]
    [Google Scholar]
  10. Chanter N., Rutter J. M., Luther P. D. 1986; Rapid detection of toxigenic Pasteurella multocida by an agar overlay method. Vet Rec 119:629–630[PubMed]
    [Google Scholar]
  11. Chen C. L., Hou W. H., Liu I. H., Hsiao G., Huang S. S., Huang J. S. 2009; Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses. J Cell Sci 122:1863–1871 [View Article][PubMed]
    [Google Scholar]
  12. Chen R. F., Lee C. Y. 2014; Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection. Int Rev Immunol 33:45–53 [View Article][PubMed]
    [Google Scholar]
  13. Christoforidis S., McBride H. M., Burgoyne R. D., Zerial M. 1999; The Rab5 effector EEA1 is a core component of endosome docking. Nature 397:621–625 [View Article][PubMed]
    [Google Scholar]
  14. Cooper J. A. 1987; Effects of cytochalasin and phalloidin on actin. J Cell Biol 105:1473–1478 [View Article][PubMed]
    [Google Scholar]
  15. Cubillos-Zapata C., Guzman E., Turner A., Gilbert S. C., Prentice H., Hope J. C., Charleston B. 2011; Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo . J Virol 85:9385–9394 [View Article][PubMed]
    [Google Scholar]
  16. de Vries E., Tscherne D. M., Wienholts M. J., Cobos-Jiménez V., Scholte F., García-Sastre A., Rottier P. J., de Haan C. A. 2011; Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog 7:e1001329 [View Article][PubMed]
    [Google Scholar]
  17. Dicks M. D., Guzman E., Spencer A. J., Gilbert S. C., Charleston B., Hill A. V., Cottingham M. G. 2015; The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species. Vaccine 33:1121–1128 [View Article][PubMed]
    [Google Scholar]
  18. Downey G. P., Botelho R. J., Butler J. R., Moltyaner Y., Chien P., Schreiber A. D., Grinstein S. 1999; Phagosomal maturation, acidification, and inhibition of bacterial growth in nonphagocytic cells transfected with FcgammaRIIA receptors. J Biol Chem 274:28436–28444 [View Article][PubMed]
    [Google Scholar]
  19. Ellis S. A., Staines K. A., Morrison W. I. 1996; cDNA sequence of cattle MHC class I genes transcribed in serologically defined haplotypes A18 and A31. Immunogenetics 43:156–159 [View Article][PubMed]
    [Google Scholar]
  20. Ellis S. A., Staines K. A., Stear M. J., Hensen E. J., Morrison W. 1998; DNA typing for BoLA class I using sequence-specific primers (PCR-SSP). Eur J Immunogenet 25:365–370 [View Article][PubMed]
    [Google Scholar]
  21. Firestone A. J., Weinger J. S., Maldonado M., Barlan K., Langston L. D., O'Donnell M., Gelfand V. I., Kapoor T. M., Chen J. K. 2012; Small-molecule inhibitors of the AAA+ ATPase motor cytoplasmic dynein. Nature 484:125–129 [View Article][PubMed]
    [Google Scholar]
  22. Ganne V., Eloit M., Laval A., Adam M., Trouve G. 1994; Enhancement of the efficacy of a replication-defective adenovirus-vectored vaccine by the addition of oil adjuvants. Vaccine 12:1190–1196 [View Article][PubMed]
    [Google Scholar]
  23. Gliddon D. R., Howard C. J. 2002; CD26 is expressed on a restricted subpopulation of dendritic cells in vivo . Eur J Immunol 32:1472–1481 [View Article][PubMed]
    [Google Scholar]
  24. Gliddon D. R., Hope J. C., Brooke G. P., Howard C. J. 2004; DEC-205 expression on migrating dendritic cells in afferent lymph. Immunology 111:262–272 [View Article][PubMed]
    [Google Scholar]
  25. Greber U. F., Willetts M., Webster P., Helenius A. 1993; Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477–486 [View Article][PubMed]
    [Google Scholar]
  26. Green C. A., Scarselli E., Sande C. J., Thompson A. J., de Lara C. M., Taylor K. S., Haworth K., Del Sorbo M., Angus B. et al. 2015; Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults. Sci Transl Med 7:300ra126 [View Article][PubMed]
    [Google Scholar]
  27. Guzman E., Taylor G., Charleston B., Skinner M. A., Ellis S. A. 2008; An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J Gen Virol 89:667–675 [View Article][PubMed]
    [Google Scholar]
  28. Guzman E., Cubillos-Zapata C., Cottingham M. G., Gilbert S. C., Prentice H., Charleston B., Hope J. C. 2012; Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation. J Virol 86:5452–5466 [View Article][PubMed]
    [Google Scholar]
  29. Hemati B., Contreras V., Urien C., Bonneau M., Takamatsu H. H., Mertens P. P., Bréard E., Sailleau C., Zientara S., Schwartz-Cornil I. 2009; Bluetongue virus targets conventional dendritic cells in skin lymph. J Virol 83:8789–8799 [View Article][PubMed]
    [Google Scholar]
  30. Hope J. C., Howard C. J., Prentice H., Charleston B. 2006; Isolation and purification of afferent lymph dendritic cells that drain the skin of cattle. Nat Protoc 1:982–987 [View Article][PubMed]
    [Google Scholar]
  31. Hope J. C., Guzman E., Cubillos-Zapata C., Stephens S. A., Gilbert S. C., Prentice H., Sopp P., Howard C. J., Charleston B. 2012; Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin. Vaccine 30:2357–2367 [View Article][PubMed]
    [Google Scholar]
  32. Howard C. J., Naessens J. 1993; Summary of workshop findings for cattle (tables 1 and 2). Vet Immunol Immunopathol 39:25–47 [View Article][PubMed]
    [Google Scholar]
  33. Howard C. J., Morrison W., Bensaid A., Davis W., Eskra L., Gerdes J., Hadam M., Hurley D., Leibold W. et al. 1991; Summary of workshop findings for leukocyte antigens of cattle. Vet Immunol Immunopathol 27:21–27 [View Article][PubMed]
    [Google Scholar]
  34. Howard C. J., Sopp P., Brownlie J., Kwong L. S., Parsons K. R., Taylor G. 1997; Identification of two distinct populations of dendritic cells in afferent lymph that vary in their ability to stimulate T cells. J Immunol 159:5372–5382[PubMed]
    [Google Scholar]
  35. Huang S., Kamata T., Takada Y., Ruggeri Z. M., Nemerow G. R. 1996; Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol 70:4502–4508[PubMed]
    [Google Scholar]
  36. Jindadamrongwech S., Smith D. R. 2004; Virus Overlay Protein Binding Assay (VOPBA) reveals serotype specific heterogeneity of dengue virus binding proteins on HepG2 human liver cells. Intervirology 47:370–373 [View Article][PubMed]
    [Google Scholar]
  37. Kalyuzhniy O., Di Paolo N. C., Silvestry M., Hofherr S. E., Barry M. A., Stewart P. L., Shayakhmetov D. M. 2008; Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo . Proc Natl Acad Sci U S A 105:5483–5488 [View Article][PubMed]
    [Google Scholar]
  38. Karger A., Mettenleiter T. C. 1996; Identification of cell surface molecules that interact with pseudorabies virus. J Virol 70:2138–2145[PubMed]
    [Google Scholar]
  39. Macia E., Ehrlich M., Massol R., Boucrot E., Brunner C., Kirchhausen T. 2006; Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10:839–850 [View Article][PubMed]
    [Google Scholar]
  40. Mallery D. L., McEwan W. A., Bidgood S. R., Towers G. J., Johnson C. M., James L. C. 2010; Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci U S A 107:19985–19990 [View Article][PubMed]
    [Google Scholar]
  41. Meier O., Gastaldelli M., Boucke K., Hemmi S., Greber U. F. 2005; Early steps of clathrin-mediated endocytosis involved in phagosomal escape of Fcgamma receptor-targeted adenovirus. J Virol 79:2604–2613 [View Article][PubMed]
    [Google Scholar]
  42. Mellman I., Fuchs R., Helenius A. 1986; Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 55:663–700 [View Article][PubMed]
    [Google Scholar]
  43. Otero M. J., Carrasco L. 1987; Proteins are cointernalized with virion particles during early infection. Virology 160:75–80 [View Article][PubMed]
    [Google Scholar]
  44. Platt C. D., Ma J. K., Chalouni C., Ebersold M., Bou-Reslan H., Carano R. A., Mellman I., Delamarre L. 2010; Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Natl Acad Sci U S A 107:4287–4292 [View Article][PubMed]
    [Google Scholar]
  45. Puntener D., Engelke M. F., Ruzsics Z., Strunze S., Wilhelm C., Greber U. F. 2011; Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J Virol 85:481–496 [View Article][PubMed]
    [Google Scholar]
  46. Rodríguez E., Everitt E. 1996; Adenovirus uncoating and nuclear establishment are not affected by weak base amines. J Virol 70:3470–3477[PubMed]
    [Google Scholar]
  47. Rossi M., Young J. W. 2005; Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol 175:1373–1381 [View Article][PubMed]
    [Google Scholar]
  48. Rothberg K. G., Heuser J. E., Donzell W. C., Ying Y. S., Glenney J. R., Anderson R. G. 1992; Caveolin, a protein component of caveolae membrane coats. Cell 68:673–682 [View Article][PubMed]
    [Google Scholar]
  49. Roy S., Clawson D. S., Calcedo R., Lebherz C., Sanmiguel J., Wu D., Wilson J. M. 2005; Use of chimeric adenoviral vectors to assess capsid neutralization determinants. Virology 333:207–214 [View Article][PubMed]
    [Google Scholar]
  50. Sakr S. W., Eddy R. J., Barth H., Wang F., Greenberg S., Maxfield F. R., Tabas I. 2001; The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin cytoskeleton, Rho family GTPases, and myosin ATPase activity. J Biol Chem 276:37649–37658 [View Article][PubMed]
    [Google Scholar]
  51. Sallusto F., Cella M., Danieli C., Lanzavecchia A. 1995; Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182:389–400 [View Article][PubMed]
    [Google Scholar]
  52. Sandgren K. J., Wilkinson J., Miranda-Saksena M., McInerney G. M., Byth-Wilson K., Robinson P. J., Cunningham A. L. 2010; A differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cells. PLoS Pathog 6:e1000866 [View Article][PubMed]
    [Google Scholar]
  53. Savina A., Amigorena S. 2007; Phagocytosis and antigen presentation in dendritic cells. Immunol Rev 219:143–156 [View Article][PubMed]
    [Google Scholar]
  54. Schwartz-Cornil I., Epardaud M., Bonneau M. 2006; Cervical duct cannulation in sheep for collection of afferent lymph dendritic cells from head tissues. Nat Protoc 1:874–879 [View Article][PubMed]
    [Google Scholar]
  55. Sirena D., Lilienfeld B., Eisenhut M., Kälin S., Boucke K., Beerli R. R., Vogt L., Ruedl C., Bachmann M. F. et al. 2004; The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J Virol 78:4454–4462 [View Article][PubMed]
    [Google Scholar]
  56. Smith J. G., Cassany A., Gerace L., Ralston R., Nemerow G. R. 2008; Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport. J Virol 82:6492–6500 [View Article][PubMed]
    [Google Scholar]
  57. Smith J. G., Wiethoff C. M., Stewart P. L., Nemerow G. R. 2010; Adenovirus. Curr Top Microbiol Immunol 343:195–224 [View Article][PubMed]
    [Google Scholar]
  58. Sonawane N. D., Thiagarajah J. R., Verkman A. S. 2002; Chloride concentration in endosomes measured using a ratioable fluorescent Cl indicator: evidence for chloride accumulation during acidification. J Biol Chem 277:5506–5513 [View Article][PubMed]
    [Google Scholar]
  59. Steinman R. M. 1991; The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271–296 [View Article][PubMed]
    [Google Scholar]
  60. Steinman R. M., Cohn Z. A. 1973; Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137:1142–1162[PubMed] [CrossRef]
    [Google Scholar]
  61. Sumida S. M., Truitt D. M., Lemckert A. A., Vogels R., Custers J. H., Addo M. M., Lockman S., Peter T., Peyerl F. W. et al. 2005; Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. J Immunol 174:7179–7185 [View Article][PubMed]
    [Google Scholar]
  62. Suomalainen M., Luisoni S., Boucke K., Bianchi S., Engel D. A., Greber U. F. 2013; A direct and versatile assay measuring membrane penetration of adenovirus in single cells. J Virol 87:12367–12379 [View Article][PubMed]
    [Google Scholar]
  63. Svensson U., Persson R. 1984; Entry of adenovirus 2 into HeLa cells. J Virol 51:687–694[PubMed]
    [Google Scholar]
  64. Taylor G., Thom M., Capone S., Pierantoni A., Guzman E., Herbert R., Scarselli E., Napolitano F., Giuliani A. et al. 2015; Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections. Sci Transl Med 7:300ra127 [View Article][PubMed]
    [Google Scholar]
  65. Tayyari F., Marchant D., Moraes T. J., Duan W., Mastrangelo P., Hegele R. G. 2011; Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med 17:1132–1135 [View Article][PubMed]
    [Google Scholar]
  66. Thom M. L., McAulay M., Vordermeier H. M., Clifford D., Hewinson R. G., Villarreal-Ramos B., Hope J. C. 2012; Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months. Clin Vaccine Immunol 19:1254–1260 [View Article][PubMed]
    [Google Scholar]
  67. Vieth J. A., Kim M. K., Pan X. Q., Schreiber A. D., Worth R. G. 2010; Differential requirement of lipid rafts for FcγRIIA mediated effector activities. Cell Immunol 265:111–119 [View Article][PubMed]
    [Google Scholar]
  68. Waddington S. N., McVey J. H., Bhella D., Parker A. L., Barker K., Atoda H., Pink R., Buckley S. M., Greig J. A. et al. 2008; Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132:397–409 [View Article][PubMed]
    [Google Scholar]
  69. Wald M., Olejár T., Sebková V., Zadinová M., Boubelík M., Poucková P. 2001; Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16. Cancer Chemother Pharmacol 47:S16–S22 [View Article][PubMed]
    [Google Scholar]
  70. Wan C. P., Park C. S., Lau B. H. 1993; A rapid and simple microfluorometric phagocytosis assay. J Immunol Methods 162:1–7 [View Article][PubMed]
    [Google Scholar]
  71. Wang L. H., Rothberg K. G., Anderson R. G. 1993; Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 123:1107–1117 [View Article][PubMed]
    [Google Scholar]
  72. West M. A., Bretscher M. S., Watts C. 1989; Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J Cell Biol 109:2731–2739[PubMed] [CrossRef]
    [Google Scholar]
  73. Whelan A. O., Hope J. C., Howard C. J., Clifford D., Hewinson R. G., Vordermeier H. M. 2003; Modulation of the bovine delayed-type hypersensitivity responses to defined mycobacterial antigens by a synthetic bacterial lipopeptide. Infect Immun 71:6420–6425 [View Article][PubMed]
    [Google Scholar]
  74. Wiethoff C. M., Wodrich H., Gerace L., Nemerow G. R. 2005; Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 79:1992–2000 [View Article][PubMed]
    [Google Scholar]
  75. Wolfrum N., Greber U. F. 2013; Adenovirus signalling in entry. Cell Microbiol 15:53–62 [View Article][PubMed]
    [Google Scholar]
  76. Yoshimori T., Yamamoto A., Moriyama Y., Futai M., Tashiro Y. 1991; Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem 266:17707–17712[PubMed]
    [Google Scholar]
  77. Zhang Y., Bergelson J. M. 2005; Adenovirus receptors. J Virol 79:12125–12131 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000581
Loading
/content/journal/jgv/10.1099/jgv.0.000581
Loading

Data & Media loading...

Supplements

Supplementary File 1

WORD

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error